Targeting Intrinsically Disordered Proteins through Dynamic Interactions

Area of Science:

• Biochemistry and Structural Biology
• Computational Biology and Drug Discovery

Background:

• Intrinsically disordered proteins (IDPs) are implicated in numerous diseases.
• Traditional drug design focuses on static structures, which is challenging for IDPs.
• Emerging evidence suggests IDPs can be targeted via dynamic interactions with small molecules.

Purpose of the Study:

• To explore the potential of targeting intrinsically disordered proteins (IDPs) using small molecules.
• To investigate the role of dynamic and transient interactions in small molecule-IDP binding.
• To highlight the need for integrated experimental and computational approaches for IDP characterization.

Main Methods:

• Utilizing enhanced sampling techniques and GPU-computing for simulations.
• Applying advanced protein force field optimization.
• Performing de novo atomistic simulations to generate reliable protein structure ensembles.
• Characterizing disordered protein ensembles.

Main Results:

• Small molecules can achieve specificity with IDPs through dynamic interactions.
• These interactions can modulate the disordered conformational ensemble.
• Modest compaction of IDPs can shield functionally important sites.

Conclusions:

• Targeting IDPs via dynamic interactions presents a promising therapeutic strategy.
• Further elucidation of the molecular basis of these interactions is crucial.
• Integrated experimental and computational frameworks, particularly physics-based simulations, are essential for advancing IDP-targeted therapies.